Metabolomics market size was valued at $2,032 Million in 2020, and is projected to reach $6,663 Million by 2030, registering a CAGR of 12.2% from 2021 to 2030.

PORTLAND, OREGON, UNITED STATES, May 15, 2023 /EINPresswire.com/ -- According to the report published by Allied Market Research, the global metabolomics market was estimated at $2.03 billion in 2020 and is expected to hit $6.66 billion by 2030, registering a CAGR of 12.2% from 2021 to 2030. The study analyzes the important strategies, drivers, competition, market dynamics, size, and important investment regions.

Key Takeaways:

Growing demand for personalized medicine and precision healthcare is driving the growth of the metabolomics market. Metabolomics plays a crucial role in understanding the biochemical processes occurring within an individual's body and can help in the development of tailored treatment plans.

Advancements in analytical techniques, such as mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy, have significantly contributed to the expansion of the metabolomics market. These technologies enable the identification and quantification of metabolites with high accuracy and sensitivity.

The pharmaceutical and biotechnology industries are the primary contributors to the metabolomics market. Metabolomics is extensively used in drug discovery and development processes, including target identification, lead optimization, and toxicity assessment.

The metabolomics market is witnessing a rising trend of collaborations and partnerships between academic research institutions, pharmaceutical companies, and metabolomics service providers. These collaborations aim to leverage each other's expertise and resources to advance metabolomics research and its applications.

North America holds the largest share in the global metabolomics market, attributed to the presence of well-established pharmaceutical and biotechnology industries, extensive research activities, and favorable government initiatives supporting metabolomics research.

Request Sample Copy of the Report: https://www.alliedmarketresearch.com/request-sample/525

Market Drivers:

Personalized Medicine and Precision Healthcare: The increasing demand for personalized medicine and precision healthcare is a significant driver for the metabolomics market. Metabolomics provides valuable insights into an individual's unique metabolic profile, allowing for targeted and personalized treatment strategies.

Drug Discovery and Development: Metabolomics plays a crucial role in the pharmaceutical and biotechnology industries, particularly in drug discovery and development. Metabolomic profiling helps identify potential drug targets, optimize lead compounds, and evaluate drug safety and efficacy.

Advancements in Analytical Techniques: Technological advancements in analytical techniques, such as mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy, have significantly enhanced the capabilities of metabolomics. These advanced techniques enable high-throughput, accurate, and sensitive analysis of metabolites, driving the growth of the metabolomics market.

Chronic Disease Management: Metabolomics offers valuable insights into the metabolic pathways and biomarkers associated with various chronic diseases, including cardiovascular diseases, diabetes, and cancer. This information can aid in early disease detection, treatment monitoring, and personalized disease management.

Agriculture and Food Industry: Metabolomics has applications in the agriculture and food industry, including crop improvement, quality assessment, and food safety. Metabolomic analysis helps identify key metabolites related to desirable traits and can contribute to the development of more resilient and nutritious crops.

Segmentation:

Technique: The market can be segmented based on the analytical techniques used in metabolomics, such as mass spectrometry, nuclear magnetic resonance (NMR) spectroscopy, chromatography, and others.

Application: Metabolomics finds applications in various sectors, including pharmaceuticals, biotechnology, agriculture, food industry, environmental studies, and others. The market can be segmented based on these application areas.

Product: The market can be segmented based on the type of products offered, including instruments (mass spectrometers, NMR spectrometers, chromatography systems), metabolomics software, and metabolite databases.

Indication: Metabolomics has applications in the study of various diseases and conditions, such as cancer, cardiovascular diseases, neurological disorders, metabolic disorders, and others. The market can be segmented based on these disease indications.

End User: The market can be segmented based on the end users of metabolomics technologies and services, including academic and research institutions, pharmaceutical and biotechnology companies, contract research organizations (CROs), and others.

Geography: The market can be segmented based on geographical regions, such as North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

Request for Customization – https://www.alliedmarketresearch.com/request-for-customization/525

Regional Growth Dynamics:

North America contributed to the major market share in terms of revenue 2020, holding more than two-fifths of the global metabolomics market, owing to surge in research activities which involve the use of metabolomics. Asia-Pacific, on the other hand, is projected to cite the fastest CAGR of 13.9% from 2021 to 2030. This is due to rise in awareness related to use of metabolomics.

Competitive Landscape:

Agilent Technologies, Inc.
Bruker Corporation
Thermo Fisher Scientific Inc.
Waters Corporation
Shimadzu Corporation
Metabolon, Inc.
Biocrates Life Sciences AG
LECO Corporation
Human Metabolome Technologies, Inc. (HMT)
Danaher Corporation (including SCIEX and Phenomenex)

Buy this Premium Research Report: https://www.alliedmarketresearch.com/purchase-enquiry/525

VALUE PROPOSITIONS RELATED TO THE REPORT:

Powered with Complimentary Analyst Hours and Expert Interviews with Each Report

Comprehensive quantitative and qualitative insights at segment and sub-segment level

Covid 19 impact trends and perspective

Granular insights at global/regional/country level

Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment

Blanket coverage on competitive landscape

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

David Correa
Allied Analytics LLP
+ +1-800-792-5285
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.